All terms in EFO
| Label | Id | Description |
|---|---|---|
| X-21444 measurement | EFO_0020016 | [Quantification of X-21444 levels in a sample.] |
| butyrylcarnitine measurement | EFO_0020010 | [Quantification of butyrylcarnitine levels in a sample.] |
| X-16964 measurement | EFO_0020011 | [Quantification of X-16964 levels in a sample.] |
| indolelactate measurement | EFO_0020012 | [Quantification of indolelactate levels in a sample.] |
| Epididymitis | HP_0000031 | [The presence of inflammation of the epididymis.] |
| polychlorinated biphenyls measurement | EFO_0007042 | [quantification in a sample of some polychlorinated biphenyls, a group of man-made environmental pollutants which accumulate in humans with adverse health effects] |
| polychlorinated biphenyls | CHEBI_35446 | |
| obese body mass index status | EFO_0007041 | [quantification of weight/height relationships above a certain threshold that classes an individual as overweight. This threshold may vary based on an individual's ethnicity but is commonly considered to correspond in European populations to a BMI > 30.] |
| body mass index | EFO_0004340 | [An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2). BMI correlates with body fat (ADIPOSE TISSUE). Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 (underweight); 18.5-24.9 (normal); 25.0-29.9 (overweight); 30.0 and above (obese). (National Center for Health Statistics, Centers for Disease Control and Prevention)] |
| blood lead measurement | EFO_0007040 | [Quantification of lead in a blood sample] |
| blood toxic metal measurement | EFO_0007574 | [Quantification of toxic metal in a blood sample] |
| lead | CHEBI_25016 | [A carbon group element atom that has formula Pb., A carbon group element that has formula Pb.] |
| perineum disease | EFO_0010689 | [Any disease of the perineum.] |
| retinal break | EFO_0010698 | [Retinal breaks are full-thickness discontinuities in the retina. They can be classified into tears, such as horseshoe tears and giant retinal tears, or holes, such as operculated holes and atrophic holes.] |
| library preparation | OBI_0000711 | [is a process which results in the creation of a library from fragments of DNA using cloning vectors or oligonucleotides with the role of adaptors., process which results in the creation of a library from fragments of DNA using cloning vectors or oligonucleotides with the role of adaptors] |
| diffuse plaque measurement | EFO_0010699 | [Quantification of diffuse plaques in the brain. Diffuse plaques are diffuse collections of aggregated amyloid-β peptide without organized internal structure (e.g. not fibrillar) and that lack dystrophic neurites or glial reaction.] |
| Alzheimer's disease neuropathologic change | EFO_0006801 | [degenerative change that occurs in individuals with Alzheimer's disease, such as amyloid plaques, cerebral amyloid angiopathy, neurofibrillary tangles, neuronal loss or synaptic loss] |
| triphalangeal thumbs-brachyectrodactyly syndrome | MONDO_0008607 | [Triphalangeal thumbs-brachyectrodactyly syndrome is characterised by triphalangeal thumbs and brachydactyly of the hands. It has been described in four families and in one isolated case. Ectrodactyly of the feet and, more rarely, ectrodactyly of the hands were also reported in some family members. Transmission is autosomal dominant.] |
| response to allogeneic hematopoietic stem cell transplant | EFO_0007044 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an allogeneic hematopoietic stem cell transplant] |
| response to transplant | EFO_0007043 | [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a transplant, generally of some form of tissue] |